727 related articles for article (PubMed ID: 31197405)
1. Metalloproteinases and their tissue inhibitors in Alzheimer's disease and other neurodegenerative disorders.
Rivera S; García-González L; Khrestchatisky M; Baranger K
Cell Mol Life Sci; 2019 Aug; 76(16):3167-3191. PubMed ID: 31197405
[TBL] [Abstract][Full Text] [Related]
2. Biological metals and metal-targeting compounds in major neurodegenerative diseases.
Barnham KJ; Bush AI
Chem Soc Rev; 2014 Oct; 43(19):6727-49. PubMed ID: 25099276
[TBL] [Abstract][Full Text] [Related]
3. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria and neurodegeneration.
Petrozzi L; Ricci G; Giglioli NJ; Siciliano G; Mancuso M
Biosci Rep; 2007 Jun; 27(1-3):87-104. PubMed ID: 17486441
[TBL] [Abstract][Full Text] [Related]
5. Resveratrol: A Focus on Several Neurodegenerative Diseases.
Tellone E; Galtieri A; Russo A; Giardina B; Ficarra S
Oxid Med Cell Longev; 2015; 2015():392169. PubMed ID: 26180587
[TBL] [Abstract][Full Text] [Related]
6. Trends in the molecular pathogenesis and clinical therapeutics of common neurodegenerative disorders.
Choonara YE; Pillay V; Du Toit LC; Modi G; Naidoo D; Ndesendo VMK; Sibambo SR
Int J Mol Sci; 2009 Jun; 10(6):2510-2557. PubMed ID: 19582217
[TBL] [Abstract][Full Text] [Related]
7. Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases.
Brkic M; Balusu S; Libert C; Vandenbroucke RE
Mediators Inflamm; 2015; 2015():620581. PubMed ID: 26538832
[TBL] [Abstract][Full Text] [Related]
8. Metalloproteinases in nervous system function and pathology: introduction.
Rivera S
Cell Mol Life Sci; 2019 Aug; 76(16):3051-3053. PubMed ID: 31175371
[TBL] [Abstract][Full Text] [Related]
9. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
10. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration.
Tenreiro S; Munder MC; Alberti S; Outeiro TF
J Neurochem; 2013 Nov; 127(4):438-52. PubMed ID: 23600759
[TBL] [Abstract][Full Text] [Related]
11. Matrix metalloproteinases and their multiple roles in neurodegenerative diseases.
Rosenberg GA
Lancet Neurol; 2009 Feb; 8(2):205-16. PubMed ID: 19161911
[TBL] [Abstract][Full Text] [Related]
12. The Role of the Metzincin Superfamily in Prostate Cancer Progression: A Systematic-Like Review.
Binder MJ; Ward AC
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808504
[TBL] [Abstract][Full Text] [Related]
13. Genetic neurodegenerative diseases: the human illness and transgenic models.
Price DL; Sisodia SS; Borchelt DR
Science; 1998 Nov; 282(5391):1079-83. PubMed ID: 9804539
[TBL] [Abstract][Full Text] [Related]
14. The role of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the pathophysiology of neurodegeneration: a literature study.
Mroczko B; Groblewska M; Barcikowska M
J Alzheimers Dis; 2013; 37(2):273-83. PubMed ID: 23792694
[TBL] [Abstract][Full Text] [Related]
15. Mitochondrial dysfunction and oxidative stress in Alzheimer's disease, and Parkinson's disease, Huntington's disease and Amyotrophic Lateral Sclerosis -An updated review.
Alqahtani T; Deore SL; Kide AA; Shende BA; Sharma R; Dadarao Chakole R; Nemade LS; Kishor Kale N; Borah S; Shrikant Deokar S; Behera A; Dhawal Bhandari D; Gaikwad N; Kalam Azad A; Ghosh A
Mitochondrion; 2023 Jul; 71():83-92. PubMed ID: 37269968
[TBL] [Abstract][Full Text] [Related]
16. Mitophagy in neurodegenerative diseases.
Rodolfo C; Campello S; Cecconi F
Neurochem Int; 2018 Jul; 117():156-166. PubMed ID: 28797885
[TBL] [Abstract][Full Text] [Related]
17. Cellular Mechanisms of Melatonin: Insight from Neurodegenerative Diseases.
Chen D; Zhang T; Lee TH
Biomolecules; 2020 Aug; 10(8):. PubMed ID: 32784556
[TBL] [Abstract][Full Text] [Related]
18. Multifaceted Role of Matrix Metalloproteinases in Neurodegenerative Diseases: Pathophysiological and Therapeutic Perspectives.
Behl T; Kaur G; Sehgal A; Bhardwaj S; Singh S; Buhas C; Judea-Pusta C; Uivarosan D; Munteanu MA; Bungau S
Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33573368
[TBL] [Abstract][Full Text] [Related]
19. Differential expressions of matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs and their endogenous inhibitors among histologic subtypes of lung cancers.
Hida Y; Hamada J
Anticancer Agents Med Chem; 2012 Sep; 12(7):744-52. PubMed ID: 22292754
[TBL] [Abstract][Full Text] [Related]
20. Tissue inhibitors of matrix metalloproteinases are elevated in cerebrospinal fluid of neurodegenerative diseases.
Lorenzl S; Albers DS; LeWitt PA; Chirichigno JW; Hilgenberg SL; Cudkowicz ME; Beal MF
J Neurol Sci; 2003 Mar; 207(1-2):71-6. PubMed ID: 12614934
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
